|
1
|
Indiková I, Much P, Stipkovits L,
Siebert-Gulle K, Szostak MP, Rosengarten R and Citti C: Role of the
GapA and CrmA cytadhesins of mycoplasma gallisepticum in promoting
virulence and host colonization. Infect Immun. 81:1618–1624.
2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Jenkins C, Geary SJ, Gladd M and
Djordjevic SP: The mycoplasma gallisepticum OsmC-like protein
MG1142 resides on the cell surface and binds heparin. Microbiology.
153:1455–1463. 2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kato M and Slack FJ: microRNAs: Small
molecules with big roles-C. elegans to human cancer. Biol Cell.
100:71–81. 2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhao Y, Wang Z, Hou Y, Zhang K and Peng X:
gga-miR-99a targets SMARCA5 to regulate mycoplasma gallisepticum
(HS strain) infection by depressing cell proliferation in chicken.
Gene. 627:239–247. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P
and Stoffel M: A pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y,
Yao H, Liu X, Ke Y, Si J and Zhou T: MiR-375 frequently
downregulated in gastric cancer inhibits cell proliferation by
targeting JAK2. Cell Res. 20:784–793. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang P, Xu LL, Li L, Ren S, Tang J, Zhang
M and Xu M: The microRNA-375 as a potentially promising biomarker
to predict the prognosis of patients with head and neck or
esophageal squamous cell carcinoma: A meta-analysis. Eur Arch
Otorhinolaryngol. 276:957–968. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Winther M, Alsner J, Tramm T, Baeksgaard
L, Holtved E and Nordsmark M: Evaluation of miR-21 and miR-375 as
prognostic biomarkers in esophageal cancer. Acta Oncol.
54:1582–1591. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Fan YP, Liao JZ, Lu YQ, Tian DA, Ye F,
Zhao PX, Xiang GY, Tang WX and He XX: MiR-375 and doxorubicin
co-delivered by liposomes for combination therapy of hepatocellular
carcinoma. Mol Ther-Nucleic Acids. 7:181–189. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
He J, Xie G, Tong J, Peng Y, Huang H, Li
J, Wang N and Liang H: Overexpression of microRNA-122 re-sensitizes
5-FU-resistant colon cancer cells to 5-FU through the inhibition of
PKM2 in vitro and in vivo. Cell Biochem Biophys. 70:1343–1350.
2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Shaker OG, Mohammed SR, Mohammed AM and
Mahmoud Z: Impact of microRNA-375 and its target gene SMAD-7
polymorphism on susceptibility of colorectal cancer. J Clin Lab
Anal. 32:2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cheng Z, Liu J, Cui Z and Zhang L: Tumors
associated with avian leukosis virus subgroup J in layer hens
during 2007 to 2009 in China. J Vet Med Sci. 72:1027–1033.
2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Payne LN, Howes K, Gillespie AM and Smith
LM: Host range of Rous sarcoma virus pseudotype RSV(HPRS-103) in 12
avian species: Support for a new avian retrovirus envelope
subgroup, designated J. J Gen Virol. 73:2995–2997. 1992.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Meng F, Li Q, Zhang Y, Cui Z, Chang S and
Zhao P: Isolation and characterization of subgroup J Avian Leukosis
virus associated with hemangioma in commercial Hy-Line chickens.
Poult Sci. 97:2667–2674. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liang X, Gu Y, Chen X, Li T, Gao Y, Wang
X, Fang C, Fang S and Yang Y: Identification and characterization
of a novel natural recombinant avian leucosis virus from Chinese
indigenous chicken flock. Virus Genes. 55:726–733. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li X, Lin W, Chang S, Zhao P, Zhang X, Liu
Y, Chen W, Li B, Shu D, Zhang H, et al: Isolation, identification
and evolution analysis of a novel subgroup of avian leukosis virus
isolated from a local Chinese yellow broiler in south China. Arch
Virol. 161:2717–2725. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Meng F, Li Q, Zhang Y, Zhang Z, Tian S,
Cui Z, Chang S and Zhao P: Characterization of subgroup J avian
Leukosis virus isolated from Chinese indigenous chickens. Virol J.
15(33)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li H, Shang H, Shu D, Zhang H, Ji J, Sun
B, Li H and Xie Q: gga-miR-375 plays a key role in tumorigenesis
post subgroup J Avian Leukosis virus infection. PLos One.
9:2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang D, He J, Dong J, Meyer TF and Xu T:
The HIPPO pathway in gynecological malignancies. Am J Cancer Res.
10:610–629. 2020.PubMed/NCBI
|
|
20
|
Ma Y, Yang Y, Wang F, Wei Q and Qin H:
Hippo-YAP signaling pathway: A new paradigm for cancer therapy. Int
J Cancer. 137:2275–2286. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Johnson R and Halder G: The two faces of
Hippo: Targeting the Hippo pathway for regenerative medicine and
cancer treatment. Nat Rev Drug Discov. 13:63–79. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bao YJ, Hata Y, Ikeda M and Withanage K:
Mammalian Hippo pathway: From development to cancer and beyond. J
Biochem. 149:361–379. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Machado-Neto JA, Lazarini M, Favaro P,
Franchi-GC Jr, Nowill AE, Saad ST and Traina F: ANKHD1, a novel
component of the Hippo signaling pathway, promotes YAP1 activation
and cell cycle progression in prostate cancer cells. Exp Cell Res.
324:137–145. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Edgar BA: From cell structure to
transcription: Hippo forges a new path. Cell. 124:267–273.
2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang H, Ramakrishnan SK, Triner D,
Centofanti B, Maitra D, Győrffy B, Sebolt-Leopold JS, Dame MK,
Varani J, Brenner DE, et al: Tumor-selective proteotoxicity of
verteporfin inhibits colon cancer progression independently of
YAP1. Sci Signal. 8(ra98)2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang H, Du YC, Zhou XJ, Liu H and Tang SC:
The dual functions of YAP-1 to promote and inhibit cell growth in
human malignancy. Cancer Metastasis Rev. 33:173–181.
2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mizuno T, Murakami H, Fujii M, Ishiguro F,
Tanaka I, Kondo Y, Akatsuka S, Toyokuni S, Yokoi K, Osada H and
Sekido Y: YAP induces malignant mesothelioma cell proliferation by
upregulating transcription of cell cycle-promoting genes. Oncogene.
31:5117–5122. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Overholtzer M, Zhang J, Smolen GA, Muir B,
Li W, Sgroi DC, Deng CX, Brugge JS and Haber DA: Transforming
properties of YAP, a candidate oncogene on the chromosome 11q22
amplicon. Proc Natl Acad Sci USA. 103:12405–12410. 2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang X, Yan Y, Lin W, Li A, Zhang H, Lei
X, Dai Z, Li X, Li H, Chen W, et al: Circular RNA Vav3 sponges
gga-miR-375 to promote epithelial-mesenchymal transition. RNA Biol.
16:118–132. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Frampton D, Schwenzer H, Marino G, Butcher
LM, Pollara G, Kriston-Vizi J, Venturini C, Austin R, de-Castro KF,
Ketteler R, et al: Molecular signatures of regression of the canine
transmissible venereal tumor. Cancer Cell.
33(620-633.e6)2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Morgan TM, Mehra R, Tiemeny P, Wolf JS, Wu
S, Sangale Z, Brawer M, Stone S, Wu CL and Feldman AS: A multigene
signature based on cell cycle proliferation improves prediction of
mortality within 5 yr of radical nephrectomy for renal cell
carcinoma. Eur Urol. 73:763–769. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Sun F, Zhang Y, Xu L, Li S, Chen X, Zhang
L, Wu Y and Li J: Proteasome inhibitor MG132 enhances
cisplatin-induced apoptosis in osteosarcoma cells and inhibits
tumor growth. Oncol Res. 26:655–664. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhu Y, Gu J, Li Y, Peng C, Shi M, Wang X,
Wei G, Ge O, Wang D, Zhang B, et al: MiR-17-5p enhances pancreatic
cancer proliferation by altering cell cycle profiles via disruption
of RBL2/E2F4-repressing complexes. Cancer Lett. 412:59–68.
2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liao Z, Dai Z, Cai C, Zhang X, Li A, Zhang
H, Yan Y, Lin W, Wu Y, Li H, et al: Knockout of Atg5 inhibits
proliferation and promotes apoptosis of DF-1 cells. In Vitro Cell
Dev Biol Anim. 55:341–348. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Giotis ES, Ross CS, Robey RC, Nohturfft A,
Goodbourn S and Skinner MA: Constitutively elevated levels of SOCS1
suppress innate responses in DF-1 immortalised chicken fibroblast
cells. Sci Rep. 7(17485)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Abu-Bonsrah KD, Zhang D and Newgreen DF:
CRISPR/Cas9 targets chicken embryonic somatic cells in vitro and in
vivo and generates phenotypic abnormalities. Sci Rep. 6(34524)2016.
View Article : Google Scholar
|
|
37
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Warren JSA, Xiao YX and Lamar JM: YAP/TAZ
activation as a target for treating metastatic cancer. Cancers.
10:2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chan SW, Lim CJ, Chen L, Chong YF, Huang
C, Song H and Hong W: The Hippo pathway in biological control and
cancer development. J Cell Physiol. 226:928–939. 2011.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zhang Y, Guan X, Chen Z, Cao D, Kang Z,
Shen Q, Lei Q, Li F, Li H, Leghari MF, et al: The high conserved
cellular receptors of avian leukosis virus subgroup J in Chinese
local chickens contributes to its wide host range. Poult Sci.
97:4187–4192. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ross CL, Kaushik S, Valdes-Rodriguez R and
Anvekar R: MicroRNAs in cutaneous melanoma: Role as diagnostic and
prognostic biomarkers. J Cell Physiol. 233:5133–5141.
2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Panagiotakopoulou M, Lendenmann T,
Pramotton FM, Giampietro C, Stefopoulos G, Poulikakos D and Ferrari
A: Cell cycle-dependent force transmission in cancer cells. Mol
Biol Cell. 29:2528–2539. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Chen BW, Chen W, Liang H, Liu H, Liang C,
Zhi X, Hu LQ, Yu XZ, Wei T, Ma T, et al: Inhibition of mTORC2
induces cell-cycle arrest and enhances the cytotoxicity of
doxorubicin by suppressing MDR1 expression in HCC cells. Mol Cancer
Ther. 14:1805–1815. 2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Li JL, Fu FQ, Wan XC, Huang SS, Wu DL and
Li Y: Up-regulated miR-29c inhibits cell proliferation and
glycolysis by inhibiting SLC2A3 expression in prostate cancer.
Gene. 665:26–34. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chen J: The cell-cycle arrest and
apoptotic functions of p53 in tumor initiation and progression.
Cold Spring Harb Perspect Med. 6(a026104)2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Li H, Ji J, Xie Q, Shang H, Zhang H, Xin
X, Chen F, Sun B, Xue C, Ma J and Bi Y: Aberrant expression of
liver microRNA in chickens infected with subgroup J avian leukosis
virus. Virus Res. 169:268–271. 2012. View Article : Google Scholar
|
|
48
|
Schlegelmilch K, Mohseni M, Kirak O,
Pruszak J, Rodriguez JR, Zhou D, Kreger BT, Vasioukhin V, Avruch J,
Brummelkamp TR and Camargo FD: Yap1 acts downstream of α-catenin to
control epidermal proliferation. Cell. 144:782–795. 2011.PubMed/NCBI View Article : Google Scholar
|
|
49
|
von Gise A, Lin ZQ, Schlegelmilch K, Honor
LB, Pan GM, Buck JN, Ma Q, Ishiwata T, Zhou B, Camargo FD and Pu
WT: YAP1, the nuclear target of Hippo signaling, stimulates heart
growth through cardiomyocyte proliferation but not hypertrophy.
Proc Natl Acad Sci USA. 109:2394–2399. 2012.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Yang Z, Zhang M, Xu K, Liu L, Hou WK, Cai
YZ, Xu P and Yao JF: Knockdown of YAP1 inhibits the proliferation
of osteosarcoma cells in vitro and in vivo. Oncol
Rep. 32:1265–1272. 2014.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Oak C, Khalifa AO, Isali I, Bhaskaran N,
Walker E and Shukla S: Diosmetin suppresses human prostate cancer
cell proliferation through the induction of apoptosis and cell
cycle arrest. Int J Oncol. 53:835–843. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Lu HF, Chen YS, Yang JS, Chen JC, Lu KW,
Chiu TH, Liu KC, Yeh CC, Chen GW, Lin HJ and Chung JG: Gypenosides
induced G0/G1 arrest via inhibition of cyclin E and induction of
apoptosis via activation of caspases-3 and -9 in human lung cancer
A-549 cells. In Vivo. 22:215–221. 2008. View Article : Google Scholar
|
|
53
|
Qie S and Diehl JA: Cyclin D1, cancer
progression, and opportunities in cancer treatment. J Mol Med
(Berl). 94:1313–1326. 2016.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Luhtala S, Staff S, Tanner M and Isola J:
Cyclin E amplification, over-expression, and relapse-free survival
in HER-2-positive primary breast cancer. Tumour Biol. 37:9813–9823.
2016.PubMed/NCBI View Article : Google Scholar
|
